Anaphylaxis and systemic mastocytosis controlled with KIT inhibitors in a patient with metastatic lung adenocarcinoma

A 58 ‐year‐old female with indolent systemic mastocytosis (ISM) and metastatic non‐ small cell lung cancer (NSCLC) presented with anaphylaxis to osimertinib with three attempts at rapid drug desensitization (RDD).

Source: Annals of Allergy, Asthma and Immunology - August 16, 2023 Category: Allergy & Immunology Authors: Camellia L. Hernandez, Donna ‐Marie Lynch, Abby Jane Golash, Kathleen Marquis, Kylie Marie Besz, Geoffrey Oxnard, Julia Rotow, Daniel J. DeAngelo, Mariana Castells Tags: Letters Source Type: research